Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
- Conditions
- Interventions
- First Posted Date
- 2024-02-13
- Last Posted Date
- 2024-02-13
- Target Recruit Count
- 300
- Registration Number
- NCT06256419
- Locations
- 🇨🇳
China, Jiangsu, Department of Endocrinology, Xuzhou, China
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- Conditions
- Interventions
- First Posted Date
- 2023-12-27
- Last Posted Date
- 2023-12-27
- Target Recruit Count
- 300
- Registration Number
- NCT06182891
- Locations
- 🇨🇳
Department of Endocrinology, Xuzhou, Jiangsu, China
Clinical Trial for Evaluating the Effectiveness and Safety of Online caIMR in STEMI Patients
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-08
- Target Recruit Count
- 335
- Registration Number
- NCT06118450
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
🇨🇳Beijing Luhe Hospital.Capital Medical University, Beijing, Beijing, China
🇨🇳Huai'an First People's Hospital, Huai'an, Jiangsu, China
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2023-10-27
- Target Recruit Count
- 14
- Registration Number
- NCT06104241
- Locations
- 🇨🇳
he Affiliated Hospital of Xuzhou Medical University, Xuzhou, JangSu, China
BGT007H Cells for the Treatment of Refractory Digestive System Tumors
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2023-10-27
- Target Recruit Count
- 14
- Registration Number
- NCT06104215
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
- Conditions
- Interventions
- First Posted Date
- 2023-07-12
- Last Posted Date
- 2023-07-12
- Target Recruit Count
- 20
- Registration Number
- NCT05941156
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2023-03-06
- Target Recruit Count
- 30
- Registration Number
- NCT05755828
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2023-02-27
- Last Posted Date
- 2023-02-27
- Target Recruit Count
- 20
- Registration Number
- NCT05745181
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells
- Conditions
- Interventions
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2023-02-24
- Target Recruit Count
- 30
- Registration Number
- NCT05744037
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
EBV CAR-T Cells for Nasopharyngeal Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2022-12-19
- Target Recruit Count
- 24
- Registration Number
- NCT05654077
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China